Targeted anticancer therapy: overexpressed receptors and nanotechnology.
about
The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeuticsSilver nanoparticles induce degradation of the endoplasmic reticulum stress sensor activating transcription factor-6 leading to activation of the NLRP-3 inflammasomeNanoparticulate carriers: an emerging tool for breast cancer therapy.Selective cancer-killing ability of metal-based nanoparticles: implications for cancer therapy.Transferrin-functionalized nanographene oxide for delivery of platinum complexes to enhance cancer-cell selectivity and apoptosis-inducing efficacy.Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers?Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma.Targeting Nanocarriers with Anisamide: Fact or Artifact?Towards understanding the distribution and tumor targeting of sericin regulated spherical calcium phosphate nanoparticles.Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles.Dually responsive mesoporous silica nanoparticles regulated by upper critical solution temperature polymers for intracellular drug delivery.Molecular photosensitisers for two-photon photodynamic therapy.Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation.Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity.
P2860
Q26795601-1EE104E2-B3D3-4560-A27C-3679E3A71763Q28388753-A9053463-1CF7-4814-A2AC-FF68D1E7550CQ38250517-B010E7A6-7510-4DBF-8246-3785F92DC013Q38557008-E01F21A4-0C7C-408D-8C69-7166644F629AQ38648996-B2992ED1-DF2B-4EB3-91A4-ADB58708DF7CQ38828904-56942856-93D3-4AAF-B45F-D1AA72A9644CQ38966649-2D771196-8242-47BA-8E86-7F8BB05B468BQ39019352-CFF58254-2388-4620-A928-2AAE3A8DC968Q39177093-CEC9CC5B-4602-4823-AF81-C3A9B81F9DB3Q40736574-B7840EE8-BEB6-4194-83A4-7942373FE6ACQ47241458-F6A571AA-6BA5-4D7E-9E6F-5B6EFA559E0AQ47370653-1B9C44BF-8726-4147-ACA6-74B88B68938CQ52684454-E9A185EF-7C1B-4337-BF74-9457A2528D71Q52757903-7FEAE38E-9F7E-4ABD-9699-74E7689F823E
P2860
Targeted anticancer therapy: overexpressed receptors and nanotechnology.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeted anticancer therapy: overexpressed receptors and nanotechnology.
@en
type
label
Targeted anticancer therapy: overexpressed receptors and nanotechnology.
@en
prefLabel
Targeted anticancer therapy: overexpressed receptors and nanotechnology.
@en
P50
P1433
P1476
Targeted anticancer therapy: overexpressed receptors and nanotechnology
@en
P2093
Sudhir Kumar
P356
10.1016/J.CCA.2014.05.004
P577
2014-05-15T00:00:00Z